# FDA recall D-0959-2017

> **Bristol-myers Squibb Company** · Class I · drug recall initiated 2017-06-05.

## Product

EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21

## Reason for recall

Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0959-2017
- **Recalling firm:** Bristol-myers Squibb Company
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-05
- **Report date:** 2017-07-19
- **Termination date:** 2022-03-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0959-2017

## Citation

> AI Analytics. FDA recall D-0959-2017. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0959-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*